Detection of flubromazolam in patients with suspected non-medical drug use attending emergency departments in the United Kingdom.

Mark HadenJosephine CashmanAndrew KetchinRebecca MacfarlaneShabana IssaMichael EddlestonSelina HinesSimon HudsonSimon L HillSimon Hugh Lynton Thomas

Published in: Clinical toxicology (Philadelphia, Pa.) (2021)

Flubromazolam has been detected frequently in drug users presenting to UK emergency departments since July 2020. Prolonged toxicity may occur as a result of the long half-life of flubromazolam and the production of metabolites likely to be active.

Keyphrases

healthcare
cross sectional
ms ms
oxidative stress
loop mediated isothermal amplification
label free
tertiary care
emergency department
adverse drug
drug induced